Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain (NCT06848348)
A Randomized, Double-Blind, Placebo Controlled, Multicenter Study With Optional Open-Label Extension to Evaluate the Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
🩺 Plain-English Summary (8th-Grade Level)
A randomized study to determine safety and efficacy of a series of subcutaneous (SC) injections of HAL in patients with CINP, compared to matching placebo injections. After that, subjects may have the option to enter an Open Label extension phase, where available, in which all subjects will receive Halneuron.
Who can join: Review the eligibility criteria below.
Location: Central Recruiting Site — Sheffield, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (25 Sites)
- Central Recruiting Site — Sheffield, Alabama
- Central Recruiting Site — Glendale, Arizona
- Central Recruiting Site — Phoenix, Arizona
- Central Recruiting Site — Fair Oaks, California
- Central Recruiting Site — Fountain Valley, California
- Central Recruiting Site — Los Angeles, California
- Central Recruiting Site — Santa Rosa, California
- Central Recruiting Site — Wheat Ridge, Colorado
- Central Recruiting Site — Jacksonville, Florida
- Central Recruiting Site — Jacksonville, Florida
- Central Recruiting Site — Lakeland, Florida
- Central Recruiting Site — Orlando, Florida
- Central Recruiting Site — Port Charlotte, Florida
- Central Recruiting Site — Tampa, Florida
- Central Recruiting Site — Gurnee, Illinois
- Central Recruiting Site — Lake Charles, Louisiana
- Central Recruiting Site — Fenton, Missouri
- Central Recruiting Site — Las Vegas, Nevada
- Central Recruiting Site — Garden City, New York
- Central Recruiting Site — Williamsville, New York
- Central Recruiting Site — Winston-Salem, North Carolina
- Central Recruiting Site — Houston, Texas
- Central Recruiting Site — McAllen, Texas
- Central Recruiting Site — Salt Lake City, Utah
- Central Recruiting Site — Madison, Wisconsin
📞 Contact the Study Coordinator
Phone: (866) 620-9255
Email: Mehran@dwtx.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Chemotherapy Induced Neuropathic Pain clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.